29th Jan 2020 07:00
LEI: 549300Q7EXQQH6KF7Z84
29 January 2020
RTW Venture Fund Limited
(the "Company")
ISSUE OF EQUITY
On 28 January 2020, the Company issued 145,000 new ordinary shares of no par value each at a price of US$1.3800 per share; these shares rank pari passu with the existing ordinary shares in issue. The issue price equates to a premium to the net asset value per share at the time of the transaction.
As a result of this issue, the total number of ordinary shares in issue now stands at 169,898,087 and the total number of voting rights in the Company is 169,898,087. There are no shares held in treasury.
The above figure of 169,898,087 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The Company confirms that application for admission will be made to London Stock Exchange plc and it is expected that admission will occur at 8:00 a.m. on 4 February 2020.
For further information, please contact:
RTW Investments, LP Stephanie Sirota, Chief Business OfficerAlexandra Taracanova, PhD, Director of Investor Relations Julia Enright, Business Development Associate
| +1 (646) 343 9280 |
J.P. Morgan Cazenove William Simmonds Ed Murray Oliver Kenyon James Bouverat (Sales) Eddie Nissen (Sales)
| +44 (0)20 7742 4000 |
Estera International Fund Managers (Guernsey) Limited Kevin Smith | +44 (0) 1481 742 642 |
Related Shares:
Rtw Biotech